eferred treatment regimen for patients who fail frontline therapy in CLL

Susan M. O’Brien , MD of University of California Irvine the preferred treatment regimen for patients who fail frontline therapy in CLL at Scripps Health 36th Annual Conference: Clinical Hematology and Oncology in San Diego.

www.scrippshealth.org/cancer